The estimated Net Worth of Ashley Mc Evoy is at least $11.7 Milion dollars as of 10 February 2023. Ms. Evoy owns over 2,999 units of Johnson & Johnson stock worth over $7,385,749 and over the last 6 years she sold JNJ stock worth over $4,276,630. In addition, she makes $0 as Executive Vice President - Worldwide Chairman a Medical Devices at Johnson & Johnson.
Ashley has made over 9 trades of the Johnson & Johnson stock since 2019, according to the Form 4 filled with the SEC. Most recently she exercised 2,999 units of JNJ stock worth $494,295 on 10 February 2023.
The largest trade she's ever made was exercising 73,323 units of Johnson & Johnson stock on 30 November 2022 worth over $5,318,850. On average, Ashley trades about 11,316 units every 81 days since 2018. As of 10 February 2023 she still owns at least 44,811 units of Johnson & Johnson stock.
You can see the complete history of Ms. Evoy stock trades at the bottom of the page.
Ashley McEvoy serves as Executive Vice President - Worldwide Chairman, Medical Devices of the Company. She joined the Company in 1996 as Assistant Brand Manager of McNeil Consumer Health, a subsidiary of the Company, advancing through positions of increasing responsibilities until she was appointed Company Group Chairman, Vision Care in 2012, followed by Company Group Chairman, Consumer Medical Devices in 2014. In July 2018, Ms. McEvoy was promoted to Executive Vice President, Worldwide Chairman, Medical Devices, and became a member of the Executive Committee. Ms. McEvoy has responsibility for the surgery, orthopaedics, interventional solutions and eye health businesses across Ethicon, DePuy Synthes, Biosense Webster and Johnson & Johnson Vision.
Ashley McEvoy is 49, she's been the Executive Vice President - Worldwide Chairman a Medical Devices of Johnson & Johnson since 2018. There are 31 older and no younger executives at Johnson & Johnson. The oldest executive at Johnson & Johnson is Ronald Williams, 70, who is the Independent Director.
Ashley's mailing address filed with the SEC is 1 PROCTER & GAMBLE PLAZA, , CINCINNATI, OH, 45202.
Over the last 21 years, insiders at Johnson & Johnson have traded over $59,929,946 worth of Johnson & Johnson stock and bought 21,998 units worth $2,578,685 . The most active insiders traders include Hubert Joly, Anne M Mulcahy a Alex Gorsky. On average, Johnson & Johnson executives and independent directors trade stock every 21 days with the average trade being worth of $4,572,436. The most recent stock trade was executed by Robert J Decker on 30 August 2024, trading 5,635 units of JNJ stock currently worth $563,838.
Johnson & Johnson is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Johnson & Johnson executives and other stock owners filed with the SEC include: